Cargando…

Use of Natural Compounds in the Management of Diabetic Peripheral Neuropathy

Nephropathy, retinopathy cardiomyopathy and peripheral neuropathy are all recognized as important complications in about 50% of diabetes mellitus (DM) patients, mostly related to a poor glycemic control or to an improper management of this pathology. In any case, amongst others, diabetic peripheral...

Descripción completa

Detalles Bibliográficos
Autores principales: Maria, Galuppo, Sabrina, Giacoppo, Placido, Bramanti, Mazzon, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271156/
https://www.ncbi.nlm.nih.gov/pubmed/24603557
http://dx.doi.org/10.3390/molecules19032877
_version_ 1783376863688654848
author Maria, Galuppo
Sabrina, Giacoppo
Placido, Bramanti
Mazzon, Emanuela
author_facet Maria, Galuppo
Sabrina, Giacoppo
Placido, Bramanti
Mazzon, Emanuela
author_sort Maria, Galuppo
collection PubMed
description Nephropathy, retinopathy cardiomyopathy and peripheral neuropathy are all recognized as important complications in about 50% of diabetes mellitus (DM) patients, mostly related to a poor glycemic control or to an improper management of this pathology. In any case, amongst others, diabetic peripheral neuropathy (DPN) seems the leading and most painful complication usually affecting many DM patients. For this reason, this work was conceived to review the large variety of strategies adopted for management of DPN, starting from the most conventional therapies to arrive at alternative approaches. From this perspective, both the most popular pharmacological treatments used to respond to the poorly effect of common analgesics—non-steroidal anti-inflammatory drugs (NSAIDS) and opioids—understood as gabapentin vs. pregabalin clinical use, and the guidelines provided by Oriental Medicine as well as by a long list of natural compounds that many authors identify as possible therapeutic or alternative agents to replace or to combine with the existing therapies will be included. Moreover, in the effort to provide the widest panel of remedies, the most antique techniques of acupuncture and electrostimulation will be considered as alternative, which are useful approaches to take into account in any non-pharmacological strategy for DPN management.
format Online
Article
Text
id pubmed-6271156
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62711562018-12-20 Use of Natural Compounds in the Management of Diabetic Peripheral Neuropathy Maria, Galuppo Sabrina, Giacoppo Placido, Bramanti Mazzon, Emanuela Molecules Review Nephropathy, retinopathy cardiomyopathy and peripheral neuropathy are all recognized as important complications in about 50% of diabetes mellitus (DM) patients, mostly related to a poor glycemic control or to an improper management of this pathology. In any case, amongst others, diabetic peripheral neuropathy (DPN) seems the leading and most painful complication usually affecting many DM patients. For this reason, this work was conceived to review the large variety of strategies adopted for management of DPN, starting from the most conventional therapies to arrive at alternative approaches. From this perspective, both the most popular pharmacological treatments used to respond to the poorly effect of common analgesics—non-steroidal anti-inflammatory drugs (NSAIDS) and opioids—understood as gabapentin vs. pregabalin clinical use, and the guidelines provided by Oriental Medicine as well as by a long list of natural compounds that many authors identify as possible therapeutic or alternative agents to replace or to combine with the existing therapies will be included. Moreover, in the effort to provide the widest panel of remedies, the most antique techniques of acupuncture and electrostimulation will be considered as alternative, which are useful approaches to take into account in any non-pharmacological strategy for DPN management. MDPI 2014-03-05 /pmc/articles/PMC6271156/ /pubmed/24603557 http://dx.doi.org/10.3390/molecules19032877 Text en © 2014 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Maria, Galuppo
Sabrina, Giacoppo
Placido, Bramanti
Mazzon, Emanuela
Use of Natural Compounds in the Management of Diabetic Peripheral Neuropathy
title Use of Natural Compounds in the Management of Diabetic Peripheral Neuropathy
title_full Use of Natural Compounds in the Management of Diabetic Peripheral Neuropathy
title_fullStr Use of Natural Compounds in the Management of Diabetic Peripheral Neuropathy
title_full_unstemmed Use of Natural Compounds in the Management of Diabetic Peripheral Neuropathy
title_short Use of Natural Compounds in the Management of Diabetic Peripheral Neuropathy
title_sort use of natural compounds in the management of diabetic peripheral neuropathy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271156/
https://www.ncbi.nlm.nih.gov/pubmed/24603557
http://dx.doi.org/10.3390/molecules19032877
work_keys_str_mv AT mariagaluppo useofnaturalcompoundsinthemanagementofdiabeticperipheralneuropathy
AT sabrinagiacoppo useofnaturalcompoundsinthemanagementofdiabeticperipheralneuropathy
AT placidobramanti useofnaturalcompoundsinthemanagementofdiabeticperipheralneuropathy
AT mazzonemanuela useofnaturalcompoundsinthemanagementofdiabeticperipheralneuropathy